Mikołaj Matłoka

Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists

Piotr Pankiewicz, Marcin Szybiński, Katarzyna Kisielewska et al. · Pharmaceuticals · 2021 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties

Jakub Staroń, Rafał Kurczab, Dawid Warszycki et al. · European Journal of Medicinal Chemistry · 2019 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and characterization of novel classes of PDE10A inhibitors - 1H-1,3-benzodiazoles and imidazo[1,2-a]pyrimidines

Rafał Moszczyński-Pętkowski, Jakub Majer, Małgorzata Borkowska et al. · European Journal of Medicinal Chemistry · 2018 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design

Adam S. Hogendorf, Adam S. Hogendorf, Agata Hogendorf et al. · European Journal of Medicinal Chemistry · 2019 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity

Katarzyna Grychowska, Rafał Kurczab, Paweł Śliwa et al. · Bioorganic & Medicinal Chemistry · 2018 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14